Literature DB >> 19931631

Direct effect of cigarette smoke on human pulmonary artery tension.

Jose Luis Ortiz1, Javier Milara, Gustavo Juan, Jose Luis Montesinos, Manuel Mata, Mercedes Ramón, Esteban Morcillo, Julio Cortijo.   

Abstract

The effect of chronic cigarette smoke on pulmonary artery (PA) tension has been studied extensively; nevertheless, the direct effect of cigarette smoke is poorly understood. We investigated the direct effect of cigarette smoke extract (CSE) on PA tension in non-smokers, smokers, and COPD patients in vitro. PA samples from 35 patients who underwent lung resection were examined by measuring isometric tension in response to increasing serotonin concentrations. CSE dose dependently inhibited the response to serotonin in smokers and COPD patients, and to a lesser extent in non-smokers. CSE-induced relaxation was similarly inhibited by the nonspecific nitric oxide synthase (NOS) inhibitor l-NOARG and the specific inducible NOS (iNOS) inhibitor l-NIL, mainly in non-smokers and smokers, and to a lesser extent in COPD patients. Immunostaining of iNOS in PA samples was greater for smokers and COPD patients compared with non-smokers, which explains the lesser effect of CSE on PA tension in non-smokers. Moreover, CSE induced the release of nitrite via iNOS in human PA smooth muscle cells. In conclusion, CSE inhibition of serotonin-induced PA contraction was mediated mainly by iNOS in non-smokers, smokers, and COPD patients, but in different ways, which may be explained by differential iNOS expression in the PA of these patients. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931631     DOI: 10.1016/j.pupt.2009.11.001

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  6 in total

1.  Roflumilast N-oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smoke in vitro.

Authors:  J Milara; M Armengot; P Bañuls; H Tenor; Rolf Beume; E Artigues; J Cortijo
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

2.  Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: molecular and functional consequences.

Authors:  J Milara; J L Ortiz; G Juan; R Guijarro; P Almudever; M Martorell; E J Morcillo; J Cortijo
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

3.  Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist.

Authors:  Javier Milara; Anselm Morell; Bea Ballester; Celia Sanz; Jose Freire; Xiaozhong Qian; Maggie Alonso-Garcia; Esteban Morcillo; Julio Cortijo
Journal:  Respir Res       Date:  2015-02-05

4.  Roflumilast N-oxide prevents cytokine secretion induced by cigarette smoke combined with LPS through JAK/STAT and ERK1/2 inhibition in airway epithelial cells.

Authors:  Tatiana Victoni; Florence Gleonnec; Manuella Lanzetti; Hermann Tenor; Samuel Valença; Luis Cristovão Porto; Vincent Lagente; Elisabeth Boichot
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

5.  Role of circulating miRNAs as biomarkers in idiopathic pulmonary arterial hypertension: possible relevance of miR-23a.

Authors:  Irene Sarrion; Lara Milian; G Juan; Mercedes Ramon; Idelfonso Furest; Carmen Carda; Julio Cortijo Gimeno; Manuel Mata Roig
Journal:  Oxid Med Cell Longev       Date:  2015-02-25       Impact factor: 6.543

6.  Effect of Liuweibuqi capsules on the balance between MMP-9 and TIMP1 and viability of alveolar macrophages in COPD.

Authors:  Chengyang Wang; Huanzhang Ding; Xiao Tang; Zegeng Li; Lei Gan
Journal:  Biosci Rep       Date:  2017-09-19       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.